Clinical application of cell‐based therapies opportunities and challenges
Clinical and Translational Discovery · 2022
DOI: 10.1002/ctd2.110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Discovery, 2022. Verfasst von Jie Gao und 1 weiteren Autor:innen. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Immune checkpoint inhibitors or anti‐cancer immunotherapy using cellular transfer have emerged as new therapies in this field. These therapies work to overcome or alleviate tumour‐induced immunosuppression, resulting in immune‐mediated tumour clearance. Cellular therapies have the largest number of active agents and clinical trials. More targets have been explored, more trials have been opened and more patients have been recruited for trials as a result of recent advancements. In this article, we describe the latest developments and major obstacles in cell therapy for cancer treatment, starting with tumour‐infiltrating T cells.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gao, J., & Wu, D. (2022). Clinical application of cell‐based therapies opportunities and challenges. Clinical and Translational Discovery. https://doi.org/10.1002/ctd2.110
Vancouver
Gao J, Wu D. Clinical application of cell‐based therapies opportunities and challenges. Clinical and Translational Discovery. 2022. doi:10.1002/ctd2.110
BibTeX
@article{Gao2022,
author = {Gao, Jie and Wu, Duojiao},
title = {Clinical application of cell‐based therapies opportunities and challenges},
journal = {Clinical and Translational Discovery},
year = {2022},
doi = {10.1002/ctd2.110}
}
EUVIMED